XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Expenses:    
Research and development $ 6,518 $ 4,430
General and administrative 2,895 1,153
Total operating expenses 9,413 5,583
Loss from operations (9,413) (5,583)
Other income (expense):    
Grant income 5,904 4,692
Change in the fair value of the derivative liability   1,063
Other (expense) income, net (195) 145
Gain on debt extinguishment   443
Interest expense, net (9) (537)
Total other income, net 5,700 5,806
Loss before income tax (3,713) 223
Income tax expense (125) 0
Net (loss) income (3,838) 223
Cumulative preferred stock dividends   (1,128)
Net loss attributable to common stockholders (3,838) (905)
Unrealized gain (loss) on foreign currency translation 1 (5)
Total comprehensive (loss) income $ (3,837) $ 218
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.17) $ (1.64)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.17) $ (1.64)
Weighted-average common shares outstanding, basic (in shares) 22,426,982 550,175
Weighted-average common shares outstanding, diluted (in shares) 22,426,982 550,175